EP3577524A1 - Semiconductor aqueous composition and use of the same - Google Patents
Semiconductor aqueous composition and use of the sameInfo
- Publication number
- EP3577524A1 EP3577524A1 EP18703964.9A EP18703964A EP3577524A1 EP 3577524 A1 EP3577524 A1 EP 3577524A1 EP 18703964 A EP18703964 A EP 18703964A EP 3577524 A1 EP3577524 A1 EP 3577524A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- aqueous composition
- semiconductor
- resist pattern
- composition according
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 131
- 239000004065 semiconductor Substances 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 claims abstract description 49
- 150000002894 organic compounds Chemical class 0.000 claims abstract description 46
- 239000004094 surface-active agent Substances 0.000 claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims description 58
- 229920005989 resin Polymers 0.000 claims description 31
- 239000011347 resin Substances 0.000 claims description 31
- 238000004140 cleaning Methods 0.000 claims description 30
- 229940024606 amino acid Drugs 0.000 claims description 26
- 235000001014 amino acid Nutrition 0.000 claims description 26
- 150000001413 amino acids Chemical class 0.000 claims description 23
- 239000002253 acid Chemical class 0.000 claims description 22
- 239000011342 resin composition Substances 0.000 claims description 18
- 150000003863 ammonium salts Chemical class 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 238000005530 etching Methods 0.000 claims description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- 229960004295 valine Drugs 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- 235000014705 isoleucine Nutrition 0.000 claims description 6
- 229960000310 isoleucine Drugs 0.000 claims description 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 6
- 229960003136 leucine Drugs 0.000 claims description 6
- 235000005772 leucine Nutrition 0.000 claims description 6
- 235000018977 lysine Nutrition 0.000 claims description 6
- 235000014393 valine Nutrition 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 5
- 239000004473 Threonine Substances 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 229960003767 alanine Drugs 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- 229960005261 aspartic acid Drugs 0.000 claims description 5
- 235000003704 aspartic acid Nutrition 0.000 claims description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 150000002391 heterocyclic compounds Chemical class 0.000 claims description 5
- 235000014304 histidine Nutrition 0.000 claims description 5
- 229960002885 histidine Drugs 0.000 claims description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 5
- 235000008729 phenylalanine Nutrition 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 229960005190 phenylalanine Drugs 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 235000008521 threonine Nutrition 0.000 claims description 5
- 229960002898 threonine Drugs 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960003121 arginine Drugs 0.000 claims description 4
- 235000009697 arginine Nutrition 0.000 claims description 4
- 230000002070 germicidal effect Effects 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- 229960002433 cysteine Drugs 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- 235000004554 glutamine Nutrition 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 235000006109 methionine Nutrition 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 229960002429 proline Drugs 0.000 claims description 3
- 235000013930 proline Nutrition 0.000 claims description 3
- 229960001153 serine Drugs 0.000 claims description 3
- 235000004400 serine Nutrition 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 229960004441 tyrosine Drugs 0.000 claims description 3
- 230000002411 adverse Effects 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 description 23
- -1 alkane diol Chemical class 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 10
- 229920002120 photoresistant polymer Polymers 0.000 description 10
- 102100023698 C-C motif chemokine 17 Human genes 0.000 description 9
- 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 239000004973 liquid crystal related substance Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 229960002989 glutamic acid Drugs 0.000 description 5
- 229960003646 lysine Drugs 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- WTQZSMDDRMKJRI-UHFFFAOYSA-N 4-diazoniophenolate Chemical compound [O-]C1=CC=C([N+]#N)C=C1 WTQZSMDDRMKJRI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 3
- 108010078777 Colistin Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 229960001127 colistin sulfate Drugs 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000001459 lithography Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 3
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 3
- KETQAJRQOHHATG-UHFFFAOYSA-N 1,2-naphthoquinone Chemical compound C1=CC=C2C(=O)C(=O)C=CC2=C1 KETQAJRQOHHATG-UHFFFAOYSA-N 0.000 description 2
- 229940105324 1,2-naphthoquinone Drugs 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241001397173 Kali <angiosperm> Species 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000002313 adhesive film Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 150000003868 ammonium compounds Chemical class 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 230000003667 anti-reflective effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001312 dry etching Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940116333 ethyl lactate Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- VPBZZPOGZPKYKX-UHFFFAOYSA-N 1,2-diethoxypropane Chemical compound CCOCC(C)OCC VPBZZPOGZPKYKX-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- XLLXMBCBJGATSP-UHFFFAOYSA-N 2-phenylethenol Chemical compound OC=CC1=CC=CC=C1 XLLXMBCBJGATSP-UHFFFAOYSA-N 0.000 description 1
- NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RNMDNPCBIKJCQP-UHFFFAOYSA-N 5-nonyl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-ol Chemical compound C(CCCCCCCC)C1=C2C(=C(C=C1)O)O2 RNMDNPCBIKJCQP-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920001665 Poly-4-vinylphenol Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- 125000004036 acetal group Chemical group 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000012648 alternating copolymerization Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000006117 anti-reflective coating Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- VUEDNLCYHKSELL-UHFFFAOYSA-N arsonium Chemical class [AsH4+] VUEDNLCYHKSELL-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JESXATFQYMPTNL-UHFFFAOYSA-N mono-hydroxyphenyl-ethylene Natural products OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 1
- LSHROXHEILXKHM-UHFFFAOYSA-N n'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCN LSHROXHEILXKHM-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000002896 organic halogen compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 125000005375 organosiloxane group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000007261 regionalization Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- SPVXKVOXSXTJOY-UHFFFAOYSA-O selenonium Chemical class [SeH3+] SPVXKVOXSXTJOY-UHFFFAOYSA-O 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000001039 wet etching Methods 0.000 description 1
- 150000003739 xylenols Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/26—Processing photosensitive materials; Apparatus therefor
- G03F7/40—Treatment after imagewise removal, e.g. baking
- G03F7/405—Treatment with inorganic or organometallic reagents after imagewise removal
Definitions
- the present invention relates to a semiconductor aqueous composition
- a surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof, and water.
- One embodiment of the present invention relates to performing cleaning in a manufacturing process of semiconductor using the semiconductor aqueous composition.
- Another embodiment of the present invention relates to a method for producing a resist pattern or a semiconductor using the semiconductor aqueous composition.
- Non-Patent Document 1 Non-Patent Document 1
- Patent Document 1 using a rinse agent containing a specific linear alkane diol, suppression of pattern collapse of a resist pattern of 20 to 500 nm and improvement of pattern width unevenness (LWR: Line width roughness) have been tried.
- LWR Line width roughness
- Patent Document 2 it has been tried to clean a liquid crystal panel in which a liquid crystal material is sealed in a 5 pm void part using a cleaning agent for a liquid crystal panel, which contains a specific surfactin.
- Patent Document 2 JP-B No. 3,758,613
- Non-Patent Document 1 "Dimensional limitations of silicon nanolines resulting from pattern distortion due to surface tension of rinse water" Namatsu et al . Appl . Phys. Lett. 1995(66) p2, 655-2, 657
- the inventors of the present invention have thought that a surfactant having high solubility in water is useful for an aqueous composition used in a manufacturing process of semiconductor, and an aqueous composition that does not adversely affect a pattern shape is useful . Further, the inventors of the present invention have noticed that the space width can be reduced, if not only the aqueous composition removes residues in the cleaning step after development, but also the resist pattern wall can be made thick. The inventors of the present invention have investigated use of a surfactant having a large molecular weight for infiltrating into a resist pattern wall to inflate it, but such a surfactant was not satisfying at solubility in water.
- the inventors of the present invention have searched for a surfactant having, regardless of a large molecular weight, high solubility in water, and tried surfactants having a polar group (for example, a nonionic surfactant to which ethylene oxide is added) .
- a surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof exhibits good solubility in water and that when it is used as a semiconductor aqueous composition, problems such as dissolution of the resist pattern wall and so on can be suppressed .
- the resist pattern produced by the method of the present invention could reduce (further make finer) the space width.
- occurrence of defects such as bridge was suppressed and better cleaning was made.
- LWR has been improved.
- an object of the present invention is to provide a useful aqueous composition to be used in a manufacturing process of semiconductor, a method for using the aqueous composition in a cleaning step, and methods for producing a resist pattern and a semiconductor.
- the semiconductor aqueous composition according to the present invention comprises a surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof, and water.
- the number of amino acids composing said organic compound is 5 to 15.
- the organic compound is represented by the following formula ( 1) .
- the semiconductor aqueous composition of the present invention may further comprise an antibacterial agent, a germicide, an antiseptic, an antifungal agent or any mixture of any of these. It may further comprise a surfactant other than said surfactant, an acid, a base, an organic solvent or any mixture of any of these.
- the semiconductor aqueous composition of the present invention is preferably a semiconductor aqueous cleaning composition.
- Another preferred embodiment of the present invention is a resist pattern cleaning composition.
- the present invention provides a method for producing a resist pattern, using the semiconductor aqueous composition.
- the producing method comprises the following steps:
- the present invention provides a method for manufacturing a semiconductor, comprising the method for producing the resist pattern.
- the semiconductor aqueous composition of the present invention exhibits good solubility of the surfactant contained therein and can suppress problems such as dissolution of a resist pattern wall . Furthermore, the resist pattern produced using the composition of the present invention can reduce the space width. In addition, with respect to the resist pattern occurrence of defects such as bridge can be suppressed and better cleaning can be made by the composition. Further, as to the pattern, LWR can be improved using the composition.
- Ci-e alkyl means an alkyl chain having 1 or more and 6 or less carbons (methyl, ethyl, propyl, butyl, pentyl, hexyl etc.).
- these repeating units copolymerize.
- these copolymerizations may be any of alternating copolymerization, random copolymerization, block copolymerization, graft copolymerization, or a mixture thereof.
- Celsius is used as the temperature unit.
- 20 degrees means 20 degrees Celsius.
- the semiconductor aqueous composition in the present invention means an aqueous composition used in a manufacturing process of semiconductor, and it is particularly preferably used in a lithography process.
- the composition of the present invention may not be one in which any semiconductor material is dissolved in a solution.
- the substance which occupies the most mass ratio in whole of the composition according to the present invention is water.
- the amount occupied by water is preferably 90 to 99.995 mass %, more preferably 95 to 99.995 mass %, and further preferably 98 to 99.99 mass % as compared with whole of the composition.
- Water is preferably pure water, DW or deionized water.
- the surfactant according to the present invention is preferably a cyclic polypeptide type biosurfactant.
- composition according to the present invention contains solvent(s) other than water.
- solvents other than water are described later.
- the surfactant in the present application means an ingredient, which acts on a surface to change its properties (hereinafter referred to as surface active ingredient) or its salt.
- the surfactant used in the present application does not include any solvent. (When a surface active ingredient or its salt is a liquid from the beginning, these are excluded.)
- a solid surface active ingredient may be dissolved in a solvent and added to a composition, but such a solvent is contained in the semiconductor aqueous composition as "water or a solvent other than water". Details are described below.
- the surfactant according to the present invention is preferably a type of biosurfactant, it is not limited to be a single compound as long as the effect of the present invention is exhibited, and it may be a mixture of plural types of surface active ingredients. Further, the surfactant in the present application also includes a state in which a surface active ingredient and its salt are mixed.
- Organic compound comprising a ring structure, said ring structure comprising peptide or salt thereof
- the semiconductor aqueous composition in the present invention comprises a surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide or a salt thereof, and water.
- the organic compound or a salt thereof also comprises an aqueous state in which it is separated into ions in an aqueous solvent of the aqueous composition.
- the number of amino acids composing the organic compound is 5 to 15.
- the number is preferably 6 to 12, and further preferably 7 to 10.
- the organic compound is not necessary to be a single one, and it may be a combination of plural ones which are different.
- the ring structure comprised in the organic compound is preferably composed by a plural amino acids and one or more assist chains.
- the amino acids composing the ring structure are independently selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
- An identical amino acid may be selected plural times.
- these amino acids form peptide bonds.
- all amino acids comprised in the ring structure compose peptide.
- amino acids composing the ring structure are independently selected from the group consisting of alanine, asparagine, aspartic acid, glutamic acid, histidine, isoleucine, leucine, lysine, phenylalanine, threonine and valine.
- the individual amino acid may be L-form or D-form.
- peptide composing the ring structure is represented by "L-glutamic acid - L-leucine - D-leucine - L-valine - L-aspartic acid - D-leucine - X", wherein X is either one of leucine, isoleucine or valine.
- R° represents a bond to a side chain (single bond) .
- one ring structure is preferably contained in the organic compound in the present invention.
- the ring structure is preferably hydrophilic as a whole. Such a ring structure is considered to have an effect of helping the organic compound to dissolve in water.
- the organic compound comprises one or more side chains, preferably one side chain.
- a linear alkyl a branched alkyl
- -NH-, -C( 0)-
- -CH(NH 2 )- -CH(OH)-
- a heterocyclic compound an amino acid or any combination of any of these.
- an identical one may be selected plural times.
- the linear alkyl is preferably Ci-io, more preferably Ci-9.
- the branched alkyl is preferably C3-10, more preferably C3-6 , and further preferably C3-4.
- the heterocyclic compound is preferably thiazole or pyrrolidine, and more preferably thiazole.
- the heterocyclic compound may compose a side chain as a linker, or may compose a side chain as a modifying group.
- the heterocyclic compound composes a side chain as a linker.
- the amino acids composing the side chain are independently selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
- An identical amino acid may be selected plural times.
- these amino acids form peptide bonds.
- all amino acids comprised in the side chain compose peptide.
- amino acids composing the side chain are independently selected from the group consisting of alanine, asparagine, aspartic acid, glutamic acid, histidine, isoleucine, leucine, lysine, phenylalanine, threonine and valine.
- the individual amino acid may be L-form or D-form.
- the side chain is preferably hydrophobic as a whole. Such a side chain is considered to have an effect of helping the organic compound to enter a resist pattern wall and to thicken the resist pattern.
- the molecular weight of the organic compound according to the present invention is preferably 700 to 2,000, and more preferably 800 to 1,500.
- the organic compound is represented by the following formula ( 1) as one preferable embodiment. side chain
- one ring structure is composed of one peptide and one assist chain, and one side chain bonds to the assist chain.
- the side chain may contain amino acid(s) .
- the surfactant of the present invention also contains a salt of the organic compound represented by the formula ( 1) .
- the organic compound can be obtained, produced and synthesized by a publicly known method. For example, it is possible to make a prokaryote or animal cell strain produce the organic compound .
- a prokaryote or animal cell strain produce the organic compound .
- the prokaryote used for the production of the organic compound microorganisms belonging to genus Bacillus such as Bacillus subtilis IAM 1213 strain, IAM 1069 strain, IAM 1260 strain, IFO 3035 strain, ATCC 21332 strain and the like can be used. By culturing and purifying this microorganism, the organic compound can be obtained . Using genetic engineering technique such as vector injection, it is also possible to make a prokaryote or animal cell strain produce the desired organic compounds.
- the organic compound according to the present invention does not have to be a single compound .
- variations in the modifications and the li ke sometimes occur, and even if such variations are present, the effect of the present invention is not so much influenced .
- A3 used in Example which is described later is not a single compound, but exhibits the effect of the present invention.
- a publicly known method can be used for purification. Purification can be done, for example, by making a culture liquid acidic by adding hydrochloric acid or the like, filtering out the organic compound precipitated, dissolving it in an organic solvent such as methanol, and then conducting ultrafiltration, activated carbon treatment, crystallization, etc.
- the acid addition can also be substituted by adding a calcium salt.
- Purification is useful for removing the organism and culture liquid that produce the organic compound .
- Surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof
- the surfactant according to the present invention may comprise a salt of an organic compound comprising a ring structure, said ring structure comprising the peptide.
- the organic compound is selected from the group consisting of metallic salt, ammonium salt, organic ammonium salt, acid salt and any mixture of any of these.
- the organic compound may be also used by changing its sodium salt to its ammonium salt. Publicly known methods can be used for changing the salt.
- alkali metals such as sodium and potassium, alkaline earth metals such as calcium and magnesium, and the like, which form a salt with the organic compound, can be used.
- organic ammonium salt salts such as trimethylamine, triethylamine, tributylamine, monoethanolamine, diethanolamine, triethanolamine, lysine, arginine and choline can be used.
- acid salt sulfate, hydrochloride, phosphate, nitrate and the like can be used.
- the salt is more preferably a sodium salt, an ammonium salt, a sulfate salt or any mixture of any of these, and more preferably a sodium salt or an ammonium salt.
- the content ratio of the surfactant of the present invention is preferably 0.005 to 2.0 mass %, more preferably 0.005 to 1.0 mass %, further preferably 0.005 to 0.5 mass %, and even more preferably 0.01 to 0.4 mass %, based on the semiconductor aqueous composition. These ratios do not contain water or other solvents.
- composition according to the present invention may comprise solvent(s) other than water.
- solvent(s) other than water for example, an organic solvent is useful for dissolving the solute contained in the composition according to the invention.
- organic solvents can be used .
- the content ratio of the organic solvent (or sum thereof in the case of plural) as compared with whole of the composition according to the present invention is preferably 0 to 9.995 mass %, more preferably 0 to 5 mass %, and further more preferably 0 to 1 mass %.
- the substance which occupies the most amount as the solvent of the composition according to the present invention is preferably water, and the content ratio of the organic solvent in the present composition is preferably 0.1 mass % or less, and further preferably 0.01 mass % or less. In relation to other layers and films, it is preferred that the present solvent contains no organic solvent, and it is one embodiment of the present invention that the content ratio of the organic solvent in the composition according to the present invention is 0.00 mass %.
- Antibacterial agent germicide, antiseptic and antifungal agent
- the composition according to the present invention may further comprise an antibacterial agent, a germicide, an antiseptic, an antifungal agent or any mixture of any of these (hereinafter referred to as antibacterial agent etc.), if needed.
- antibacterial agent etc. an antibacterial agent used to prevent bacteria or fungi from breeding in the aqueous composition over time.
- the organic compound according to the present invention comprises peptide, it is important to use an antibacterial agent etc. in order to ensure the stability of the present composition.
- antibacterial agent etc. include alcohols such as phenoxyethanol and isothiazolone.
- BESTCIDE trade name of Nippon Soda Co., Ltd.
- a composition comprising one kind of antibacterial agent can be referred.
- the content ratio of the antibacterial agent etc. (or sum thereof in the case of plural) as compared with whole of the composition of the present invention is preferably 0.0001 to 1 mass %, and more preferably 0.0001 to 0.01 mass %.
- composition according to the present invention may further comprise a surfactant other than the surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof (hereinafter referred to as other surfactant) .
- a surfactant other than the surfactant comprising an organic compound comprising a ring structure, said ring structure comprising peptide, or a salt thereof (hereinafter referred to as other surfactant) .
- the content ratio of the surfactant in the present composition as compared with whole of the composition of the present invention is preferably 0.01 to 5 mass %, and more preferably 0.05 to 3 mass %.
- polyoxyethylene alkyl ether compounds such as polyoxyethylene lauryl ether, polyoxyethylene stearyl ether and polyoxyethylene oleyl ether; polyoxyethylene al kylaryl ether compounds such as polyoxyethylene octylphenol ether and polyoxyethylene nonylphenol ether; polyoxyethylene / polyoxypropylene block copolymer compounds; sorbitan fatty acid ester compounds such as sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan trioleate and sorbitan tristearate; polyoxyethylene sorbitan fatty acid ester compounds such as polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate and polyoxyethylene sorbitan tristearate can be referred.
- fluorine-based surfactants such as EFTOP EF301, EF303 and EF352 (trade name, manufactured by Tochem Products Co., Ltd. ), MEGAFAC F171, F173, R-08, R-30 and R-2011 (trade name, manufactured by DIC Corporation), FLUORAD FC430 and FC431 (trade name, manufactured by Sumitomo 3M Limited), ASAHI GUARD AG710 and SURFLON S-382, SC101, SC102, SC103, SC104, SC105 and SC106 (trade name, manufactured by Asahi Glass Co., Ltd. ), and organosiloxane polymer KP 341 (manufactured by Shin-Etsu Chemical Co., Ltd .), and the like can be referred.
- EFTOP EF301, EF303 and EF352 trade name, manufactured by Tochem Products Co., Ltd.
- MEGAFAC F171, F173, R-08, R-30 and R-2011 trade name, manufactured by DIC Corporation
- the acid or base is used to adjust the pH of treating liquid or to improve the solubility of adding component.
- the acid or base to be used can be arbitrarily selected as long as the effect of the present invention is not impaired, and examples thereof include carboxylic acids, amines and ammonium compounds. These include fatty acids, aromatic carboxylic acids, primary amines, secondary amines, tertiary amines, and ammonium compounds, and these may be substituted by any substituent or not substituted.
- the amount of the acid is preferably 0.005 to 0.1 mass % as compared with whole of the composition of the present invention.
- the amount of the base is preferably 0.01 to 0.3 mass % as compared with whole of the composition of the present invention.
- the semiconductor aqueous composition according to the present invention after the solute is dissolved, it is possible to remove insoluble matter by filtration through a filter.
- composition according to the present invention is to be used for cleaning in a manufacturing process of semiconductor.
- the semiconductor aqueous composition is preferably a semiconductor aqueous cleaning composition.
- one embodiment of the present invention is to be used for cleaning a resist pattern formed by exposing / developing (lithography technique) a resist film. That is, the semiconductor aqueous composition is more preferably a resist pattern cleaning composition.
- the cleaning composition is used in a manufacturing process of semiconductor.
- the resist pattern includes not only one obtained by exposing / developing a resist film but also one having a wall thickened by further covering it with other layer(s) or film(s) (one in which its space width is further made finer) .
- the resist pattern is further made finer by a resin composition.
- the lithography process in the method may be any of the method for forming a resist pattern using a publicly known positive or negative type photosensitive resin composition (resist composition), which is a type of developing with an aqueous alkaline solution.
- resist composition a publicly known positive or negative type photosensitive resin composition
- Representative pattern forming methods to which the semiconductor aqueous composition of the present invention is applied include the following methods.
- a photosensitive resin composition is applied on a substrate such as a silicon substrate, a glass substrate, or the like, which has been optionally pretreated, to form a photosensitive resin layer.
- a publicly known method can be used for the application, but a coating method such as spin coating is suitable.
- the photosensitive resin composition may be directly applied on a substrate, or may be applied via one or more intermediate layers (for example, a BARC layer) .
- an anti-reflective film for example, a TARC layer
- Layers other than the photosensitive resin layer are described later.
- Typical examples of publicly known positive or negative type photosensitive resin composition of a type of developing with an al kaline developing solution used in the resist pattern producing method of the present invention include one comprising a quinone diazide type photosensitizer and an alkali soluble resin, a chemically amplified photosensitive resin composition, and the like. From the viewpoint of forming a fine resist pattern with high resolution, a chemically amplified photosensitive resin composition is preferable and, for example, a chemically amplified PHS-acrylate hybrid type EUV resist composition can be referred.
- Examples of the quinone diazide type photosensitizer used in the above-described positive type photosensitive resin composition comprising the quinone diazide type photosensitizer and the alkali soluble resin include 1,2-benzoquinone diazide-4-sulfonic acid, 1,2-naphthoquinone diazide-4-sulfonic acid, 1,2-naphthoquinone diazide-5-sulfonic acid, esters or amides of these sulfonic acids, and examples of the alkali soluble resin include novolac resin, polyvinyl phenol, polyvinyl alcohol, copolymer of acrylic acid or methacrylic acid, and the like.
- the novolac resin include one produced from one or more phenols such as phenol, o-cresol, m-cresol, p-cresol and xylenol, and one or more aldehydes such as formaldehyde and paraformaldehyde.
- phenols such as phenol, o-cresol, m-cresol, p-cresol and xylenol
- aldehydes such as formaldehyde and paraformaldehyde.
- the chemically amplified photosensitive resin composition includes a positive type chemically amplified photosensitive resin composition comprising a compound (photoacid generator) that generates an acid upon irradiation with active ray or radiation, and a resin whose polarity is increased by the action of the acid generated from the photoacid generator and whose solubility to a developing solution varies in an exposed part and an unexposed part; or a negative type chemically amplified photosensitive resin composition comprising an al kali soluble resin, a photo acid generator and a crosslinking agent, in which crosslinking of the resin due to the crosslinking agent is caused by action of the acid and the solubility to a developing solution varies in an exposed part and an unexposed part.
- a positive type chemically amplified photosensitive resin composition comprising a compound (photoacid generator) that generates an acid upon irradiation with active ray or radiation, and a resin whose polarity is increased by the action of the acid generated from the photoacid generator and
- a resin having a group which is decomposed due to the action of acid to form an alkali soluble group in the main chain or side chain of the resin or both main chain and side chain thereof can be referred .
- Typical examples thereof include polymer in which an acetal group or a ketal group is introduced as a protective group to a hydroxystyrene-based polymer (PHS) (for example, JP-A No. 2- 141,636, J P-A No.
- the photoacid generator may be any compound as long as it generates an acid upon irradiation with active ray or radiation, and examples thereof include onium salts such as diazonium salts, ammonium salts, phosphonium salts, iodonium salts, sulfonium salts, selenonium salts and arsonium salts, organic halogen compounds, organometallic compounds / organic halides, photoacid generators having an o-nitrobenzyl type protective group, compounds capable of photolysis to generate a sulfonic acid represented by iminosulfonate and the like, disulfone compounds, diazoketosulfones, diazodisulfone compounds, and the like.
- Compounds in which a group or compound capable of generating an acid by light is introduced into the main chain or the side chain of polymer can also be used.
- said chemically amplified photosensitive resin composition may further comprise, if needed, an acid decomposable and dissolution inhibiting compound, a dye, a plasticizer, a surfactant, a photosensitizer, an organic basic compound, and a compound that promotes solubility to developing solution, and the like.
- said photosensitive resin composition is applied onto a substrate by a suitable coating apparatus such as a spinner and a coater by means of a suitable coating method and soft-baked on a hot plate to remove the solvent in the photosensitive resin composition, thereby forming a photosensitive resin layer.
- the soft baking temperature varies depending on the solvent or the resist composition to be used, but is generally 70 to 150°C, and preferably 90 to 150°C. It can be carried out for 10 to 180 seconds, preferably for 30 to 90 seconds in the case of hot plate, or for 1 to 30 minutes in the case of clean oven.
- the presence of film(s) or layer(s) other than the photosensitive resin layer is also allowed .
- intermediate layer(s) may be interposed .
- the intermediate layer is a layer formed between a substrate and a photosensitive resin layer and is referred also to as underlayer film .
- a substrate modifying film, a planarizing film, a bottom anti-reflecting coating (BARC layer), an inorganic hard mask intermediate layer (silicon oxide film, silicon nitride film and silicon oxide nitride film) can be referred .
- BARC layer bottom anti-reflecting coating
- an inorganic hard mask intermediate layer silicon oxide film, silicon nitride film and silicon oxide nitride film
- the intermediate layer may be composed of one or more layers.
- a top anti-reflective coating (TARC layer) may be formed on the photosensitive resin layer.
- any publicly known technique can be used in accordance with process conditions.
- the following layer constitution can be referred.
- These layers can be obtained by coating and thereafter heating and / or exposing to cure, or by employing a publicly known method such as CVD method to form a film . These layers can be removed by a publicly known method (etching or the like), and can be patterned using the upper layer as a mask.
- the photosensitive resin layer is exposed through a predetermined mask. When other layers (TARC layer etc.) are also included, they may be exposed together.
- the wavelength of the light used for exposure is not particularly limited, but it is preferable to perform exposure with light having a wavelength of 13.5 to 248 nm. Specifically, KrF excimer laser (wavelength : 248 nm), ArF excimer laser (wavelength : 193 nm), extreme ultraviolet ray (wavelength : 13.5 nm) and the like can be used, and extreme ultraviolet ray is more preferable. These wavelengths allow a range of ⁇ 5%, and preferably a range of ⁇ 1% .
- post exposure bake may be performed, if needed.
- the temperature for post-exposure heating is appropriately selected from 70 to 150°C, preferably 80 to 120°C, and the heating time is appropriately selected from 0.3 to 5 minutes, preferably 0.5 to 2 minutes.
- a developing solution for the development in the method for producing the resist pattern of the present invention, a 2.38 mass % TMAH aqueous solution is preferably used . Further, a surfactant or the like can be added to these developers.
- the temperature of the developing solution is appropriately selected from 5 to 50°C, preferably 25 to 40°C, and the developing time is appropriately selected from 10 to 300 seconds, preferably from 20 to 60 seconds.
- publicly known methods such as paddle development can be used.
- the resist pattern of the present invention includes not only one obtained by exposing / developing a resist film but also one having a wall thickened by further covering it with other layer(s) or film(s) .
- the resist pattern (the developed photosensitive resin layer) formed up to the above steps is in a non-cleaned state.
- This resist pattern can be cleaned with the semiconductor aqueous composition of the present invention.
- the time for bringing the semiconductor aqueous composition into contact with the resist pattern, that is, the treatment time is preferably 1 second or more.
- the treating temperature may be also arbitrary.
- the method for bringing a rinse liquid into contact with the resist is also arbitrary, and it can be done, for example, by immersing a resist substrate in a rinse liquid or dropping a rinse liquid onto a rotating resist substrate surface.
- the resist pattern after being developed can be cleaned with other cleaning liquid before and / or after the cleaning treatment with the semiconductor aqueous composition.
- the other cleaning liquid is preferably water, and more preferably pure water.
- the cleaning before the treatment is useful for cleaning the developing solution that has adhered to the resist pattern.
- the cleaning after the treatment is useful for cleaning the semiconductor aqueous composition.
- One preferred embodiment of the production method of the present invention is a method comprising, by pouring pure water onto a resist pattern, cleaning the pattern after being developed while substituting the developing solution, and further, by pouring the semiconductor aqueous composition while keeping the pattern immersed in pure water, cleaning the pattern while substituting pure water.
- the cleaning with the semiconductor aqueous composition may be carried out by any conventionally known method. It can be done, for example, by immersing a resist substrate in the semiconductor aqueous composition, or by dropping the semiconductor aqueous composition onto a rotating resist substrate surface. These methods may be carried out in appropriate combination thereof.
- the bridge is one in which undesired structure(s) exist in the groove(s) of a resist pattern and is a kind of defect. The reason includes that the resist patterns (walls) are connected to each other or that foreign substance which should be flowed is caught in the groove and remains therein. When a desired groove is filled with bridge(s), it becomes impossible to design a desired circuit in a following process such as etching.
- one semiconductor includes one circuit unit in the horizontal direction and a plural circuit units in the vertical direction.
- the occurrence frequency of the portion where the interval between a wall and a wall is narrow is low, the occurrence frequency of defects decreases, so that the occurrence frequency of defective products decreases.
- the minimum space size of the resist pattern in one circuit unit is preferably 10 to 30 nm, more preferably 15 to 25 nm, and further preferably 18 to 22 nm.
- the resist pattern produced by the method of the present invention could reduce the space width (make further finer) as compared with the case of cleaning with pure water.
- the space width means a width of a trench (groove) between a wall and a wall, of a resist pattern.
- the resist pattern which can be produced by using the method of the present invention can reduce the space width preferably 0.5 to 5 nm, more preferably 1.0 to 2.0 nm, and further preferably 1.3 to 2.4 nm, as compared with the case of cleaning with pure water.
- the resist pattern produced by the method of the present invention could make the LWR small . This is considered to be useful for raising the yield rate.
- an intermediate layer and/or a substrate can be patterned .
- publicly known methods such as etching (dry etching and wet etching) can be used.
- etching dry etching and wet etching
- an intermediate layer is etched using a resist pattern as an etching mask, and a substrate can be etched using the obtained intermediate layer pattern as an etching mask to form a pattern on the substrate.
- a photoresist pattern as an etching mask, to etch a substrate as it is while etching layer(s) (for example, intermediate layer) lower than the photoresist layer.
- Wiring can be formed on the substrate utilizing the formed pattern.
- These layers can be removed, preferably by dry etching with O2, CF 4 , CH F3, CI 2 or BCh, and preferably, O2 or CF 4 can be used.
- the substrate is further processed, if needed, and a device is formed .
- a device is formed .
- publicly known methods can be applied.
- the substrate is optionally cut into chips, connected to a lead frame, and packaged with resin.
- this packaged product is called semiconductor.
- FIG . 1 is an SEM image of a resist pattern having a space width where bridge(s) have occurred in case of Comparative Composition 1.
- FIG . 2 is an SEM image of a resist pattern having a minimum space width in case of Comparative Composition 1.
- FIG. 3 is an enlarged figure of FIG. 1.
- FIG. 4 is an enlarged figure of FIG. 2.
- Colistin sulfate A CH 3
- A3 columnistin sulfate, model number C2930, manufactured by Tokyo Chemical Industry Co., Ltd .
- A4 was prepared as a solution by changing Al to its ammonium salt in the following process.
- Example Composition 1 0.2 g of Al was added to 1,000 g of pure water, and this was stirred and completely dissolved to obtain a 0.02 mass % aqueous solution of Al . This solution was designated as Example Composition 1.
- the additives and their concentrations in Example Compositions were summarized in Table 1.
- compositions were prepared in the same manner as in Preparation Example 1 except that the surfactants and concentrations were changed as described in Table 1. In Comparative Preparation Example 1, no surfactant was added.
- Example Compositions 2 to 6 were designated as Example Compositions 2 to 6 and Comparative Compositions 1 to 3, respectively.
- Example Composition 7 5.0 g of the above-described A4 solution was batched off. This was added to 245 g of pure water, stirred, and completely dissolved . This solution was designated as Example Composition 7.
- the mass % in Table 1 shows the mass % of the present organic compound as a solute.
- the substrate for evaluation used for following evaluation was prepared as shown below.
- the surface of a silicon substrate (manufactured by SUMCO Corporation, 12 inches) was treated with a 1, 1, 1,3,3,3-hexamethyldisilazane solution at 90°C for 30 seconds.
- a chemically amplified PHS-acrylate hybrid type EUV resist composition was spin-coated thereon and soft-baked at 110°C for 60 seconds, thereby forming a resist film having a thickness of 50 nm on the substrate.
- This was exposed through a mask of line : space 3 : 1 (78 nm : 26 nm) with an extreme ultraviolet stepper NXE : 3100 (manufactured by ASM L Holding N. V.) .
- Plural exposure amounts were set, and substrates of each condition were obtained . As the exposure amount increases, the space width of the resist pattern formed by later development increases.
- This substrate was post-exposure baked (PEB) at 100°C for 60 seconds. Thereafter, the resist film was subjected to puddle development for 30 seconds using a 2.38% tetramethylammonium hydroxide (TMAH) aqueous solution.
- TMAH tetramethylammonium hydroxide
- pure water was started to flow onto the substrate, the puddle developing solution was replaced, while rotating, with pure water, and the flowing was stopped in a state of being puddled with pure water. Then, each composition shown in Table 1 was poured into this, and the substrate was rotated at a high speed, thereby spin-dried.
- the space width reduction amount was evaluated as follows.
- the space width of Comparative Composition 1 to which no surfactant was added was measured with a SEM instrument, CG 5000 (manufactured by Hitachi High-Technologies Corporation), and found to be 26.0 nm.
- CG 5000 manufactured by Hitachi High-Technologies Corporation
- the space widths treated with Example Compositions 1 to 7 and Comparative Composition 2 were similarly measured.
- the difference between the obtained space width and the space width treated with Comparative Composition 1 is shown in Table 1 as the space width reduction amount.
- the space width treated with Example Composition 1 was 24.2 nm, and the space width was narrower by 1.8 nm than that treated with Comparative Composition 1 (26.0 nm) . It was confirmed that in the resist pattern on the substrate for evaluation, which was treated with Example Compositions 1 to 7, the space width could be made narrower than that treated with water (Comparative Composition 1) .
- the space width of the resist pattern was measured with the above described SEM instrument, CG 5000, and it was observed whether or not bridge(s) had occurred in the space.
- a substrate for evaluation which was prepared with a next smaller exposure amount, was evaluated . This process was repeated until occurrence of any bridge was confirmed .
- the space width of the resist pattern of the substrate for evaluation was designated as space width where a bridge occurred .
- the space width of a substrate for evaluation (that prepared with a next larger exposure amount) evaluated just before the substrate for evaluation was designated as minimum space width.
- the minimum space width was 22.6 nm
- the space width of the substrate for evaluation where bridge occurrence was confirmed was 21.8 nm.
- FIG. 1 to 4 show SEM images of the resist pattern with the space width and the minimum space width where a bridge occurred, in case of Comparative Composition 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cleaning Or Drying Semiconductors (AREA)
- Photosensitive Polymer And Photoresist Processing (AREA)
- Detergent Compositions (AREA)
- Exposure And Positioning Against Photoresist Photosensitive Materials (AREA)
- Peptides Or Proteins (AREA)
- Exposure Of Semiconductors, Excluding Electron Or Ion Beam Exposure (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017019871A JP2018127513A (ja) | 2017-02-06 | 2017-02-06 | 半導体水溶性組成物、およびその使用 |
PCT/EP2018/052726 WO2018141944A1 (en) | 2017-02-06 | 2018-02-05 | Semiconductor aqueous composition and use of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3577524A1 true EP3577524A1 (en) | 2019-12-11 |
Family
ID=61188793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18703964.9A Withdrawn EP3577524A1 (en) | 2017-02-06 | 2018-02-05 | Semiconductor aqueous composition and use of the same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3577524A1 (ja) |
JP (2) | JP2018127513A (ja) |
TW (1) | TWI800500B (ja) |
WO (1) | WO2018141944A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020188090A (ja) * | 2019-05-13 | 2020-11-19 | Jsr株式会社 | コバルトを含む基板を処理するための半導体洗浄用または化学機械研磨用組成物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3817012A1 (de) | 1988-05-19 | 1989-11-30 | Basf Ag | Positiv und negativ arbeitende strahlungsempfindliche gemische sowie verfahren zur herstellung von reliefmustern |
DE68926019T2 (de) | 1988-10-28 | 1996-10-02 | Ibm | Positiv arbeitende hochempfindliche Photolack-Zusammensetzung |
JPH02141636A (ja) | 1988-11-24 | 1990-05-31 | Kawasaki Steel Corp | 油圧システムの内部リーク診断方法 |
DE69027799T2 (de) | 1989-03-14 | 1997-01-23 | Ibm | Chemisch amplifizierter Photolack |
DE4007924A1 (de) | 1990-03-13 | 1991-09-19 | Basf Ag | Strahlungsempfindliches gemisch |
DE4202845A1 (de) | 1992-01-31 | 1993-08-05 | Basf Ag | Strahlungsempfindliches gemisch |
JP3751065B2 (ja) | 1995-06-28 | 2006-03-01 | 富士通株式会社 | レジスト材料及びレジストパターンの形成方法 |
JP3380128B2 (ja) | 1996-11-29 | 2003-02-24 | 富士通株式会社 | レジスト材料及びレジストパターンの形成方法 |
JP3297272B2 (ja) | 1995-07-14 | 2002-07-02 | 富士通株式会社 | レジスト組成物及びレジストパターンの形成方法 |
JP3758613B2 (ja) * | 2002-06-28 | 2006-03-22 | 昭和電工株式会社 | 液晶パネル用洗浄剤組成物 |
JP4657899B2 (ja) * | 2005-11-30 | 2011-03-23 | 富士通株式会社 | レジストパターン厚肉化材料、レジストパターンの形成方法、半導体装置及びその製造方法 |
JP5069494B2 (ja) | 2007-05-01 | 2012-11-07 | AzエレクトロニックマテリアルズIp株式会社 | 微細化パターン形成用水溶性樹脂組成物およびこれを用いた微細パターン形成方法 |
JP5336306B2 (ja) | 2008-10-20 | 2013-11-06 | 信越化学工業株式会社 | レジスト下層膜形成方法、これを用いたパターン形成方法、及びレジスト下層膜材料 |
US8747886B2 (en) * | 2009-02-12 | 2014-06-10 | Tufts University | Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications |
JP5624753B2 (ja) * | 2009-03-31 | 2014-11-12 | 東京応化工業株式会社 | リソグラフィー用洗浄液及びこれを用いたレジストパターンの形成方法 |
JP6063879B2 (ja) * | 2011-03-18 | 2017-01-18 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 集積回路デバイス、光デバイス、マイクロマシン及び線幅50nm以下のパターニングされた材料層を有する機械的精密デバイスの製造方法 |
JP5830444B2 (ja) * | 2012-07-02 | 2015-12-09 | 信越ポリマー株式会社 | 導電性高分子組成物、該組成物より得られる帯電防止膜が設けられた被覆品、及び前記組成物を用いたパターン形成方法。 |
JP6106990B2 (ja) | 2012-08-27 | 2017-04-05 | 富士通株式会社 | リソグラフィ用リンス剤、レジストパターンの形成方法、及び半導体装置の製造方法 |
JP6555595B2 (ja) * | 2014-03-05 | 2019-08-07 | 株式会社カネカ | 臨界ミセル濃度の低減方法 |
WO2016159886A1 (en) * | 2015-03-31 | 2016-10-06 | Agency For Science, Technology And Research | Self-assembling ultrashort aliphatic cyclic peptides for biomedical applications |
-
2017
- 2017-02-06 JP JP2017019871A patent/JP2018127513A/ja active Pending
-
2018
- 2018-02-05 TW TW107104027A patent/TWI800500B/zh active
- 2018-02-05 JP JP2019533626A patent/JP7200110B2/ja active Active
- 2018-02-05 EP EP18703964.9A patent/EP3577524A1/en not_active Withdrawn
- 2018-02-05 WO PCT/EP2018/052726 patent/WO2018141944A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2020507915A (ja) | 2020-03-12 |
JP2018127513A (ja) | 2018-08-16 |
TWI800500B (zh) | 2023-05-01 |
JP7200110B2 (ja) | 2023-01-06 |
WO2018141944A1 (en) | 2018-08-09 |
TW201840837A (zh) | 2018-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101967189B1 (ko) | 자기 정렬 스페이서를 포함하는 기판 | |
KR101698400B1 (ko) | 전자 장치 형성 방법 | |
US7897325B2 (en) | Lithographic rinse solution and method for forming patterned resist layer using the same | |
WO2012020747A1 (ja) | リソグラフィー用リンス液およびそれを用いたパターン形成方法 | |
US20230167383A1 (en) | Electronic device manufacturing aqueous solution, method for manufacturing resist pattern and method for manufacturing device | |
TW201544918A (zh) | 塗佈於光阻圖型之含聚合物塗佈液 | |
KR101921892B1 (ko) | 리소그래피용 린스액 및 이를 사용한 패턴 형성 방법 | |
JP7200110B2 (ja) | 半導体水溶性組成物、およびその使用 | |
TW201627781A (zh) | 光阻圖案處理用組成物及使用其之圖案形成方法 | |
US20050109992A1 (en) | Photoresist cleaning solutions and methods for pattern formation using the same | |
JP7411702B2 (ja) | 半導体水溶性組成物およびその使用 | |
TW202319530A (zh) | 電子設備製造用水溶液、光阻圖案之製造方法及裝置之製造方法 | |
TW202342709A (zh) | 電子設備製造液、光阻圖案之製造方法及裝置之製造方法 | |
JP2006154004A (ja) | リソグラフィー用現像前処理剤、それを用いたパターン形成方法及びパターン形成材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190729 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MERCK PATENT GMBH |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230519 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20230901 |